Table 4a.
3D CE MRAV | PP | PP% | SP | SP% | RR | RR% |
---|---|---|---|---|---|---|
R Carotid Ectasia | 0 | 0.0% | 4 | 9.1% | 2 | 2.3% |
L Carotid Ectasia | 2 | 5.1% | 6 | 13.6% | 13 | 14.9% |
R Enhancement Delay | 2 | 5.1% | 4 | 9.1% | 1 | 1.1% |
L Enhancement Delay | 1 | 2.6% | 1 | 2.3% | 1 | 1.1% |
R Aplasia | 0 | 0.0% | 1 | 2.3% | 0 | 0.0% |
L Aplasia | 1 | 2.6% | 0 | 0.0% | 0 | 0.0% |
R T1 Atresia | 1 | 2.6% | 1 | 2.3% | 0 | 0.0% |
L T1 Atresia | 2 | 5.1% | 3 | 6.8% | 1 | 1.1% |
R C6 Atresia | 1 | 2.6% | 2 | 4.5% | 0 | 0.0% |
L C6 Atresia | 1 | 2.6% | 4 | 9.1% | 4 | 4.6% |
R C2 Atresia | 1 | 2.6% | 2 | 4.5% | 2 | 2.3% |
L C2 Atresia | 5 | 12.8% | 4 | 9.1% | 5 | 5.7% |
R Diffuse | 0 | 0.0% | 0 | 0.0% | 2 | 2.3% |
L Diffuse | 3 | 7.7% | 1 | 2.3% | 4 | 4.6% |
R T1 No signal | 1 | 2.6% | 2 | 4.5% | 0 | 0.0% |
R C6 No signal | 1 | 2.6% | 2 | 4.5% | 0 | 0.0% |
R C2 No signal | 0 | 0.0% | 2 | 4.5% | 2 | 2.3% |
L T1 No signal | 3 | 7.7% | 3 | 6.8% | 1 | 1.1% |
L C6 No signal | 1 | 2.6% | 5 | 11.4% | 4 | 4.6% |
L C2 No signal | 3 | 7.7% | 3 | 6.8% | 4 | 4.6% |
R T1 Stenosis | 5 | 12.8% | 7 | 15.9% | 16 | 18.4% |
R C6 Stenosis | 4 | 10.3% | 4 | 9.1% | 3 | 3.4% |
R C2 Stenosis | 0 | 0.0% | 1 | 2.3% | 1 | 1.1% |
L T1 Stenosis | 7 | 17.9% | 6 | 13.6% | 20 | 23.0% |
L C6 Stenosis | 10 | 25.6% | 5 | 11.4% | 12 | 13.8% |
L C2 Stenosis | 2 | 5.1% | 2 | 4.5% | 5 | 5.7% |
R Stenosis* | 13 | 33.3% | 15 | 34.1% | 24 | 27.6% |
L Stenosis* | 20 | 51.3% | 17 | 38.6% | 38 | 43.7% |
The number of patients with stenosis independent of how many criteria were used.